Cargando…

The role of mitofilin in left ventricular hypertrophy in hemodialysis patients

Left ventricular hypertrophy (LVH) is a common abnormality in hemodialysis (HD) patients. Mitochondrial dysfunction contributes to the progression of LVH. As an inner mitochondrial membrane structural protein, mitofilin plays a key role in maintaining mitochondrial structure and function. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Qi-Shun, He, Qing, He, Jian-Qiang, Chao, Jun, Wang, Wen-Yan, Zhou, Yan, Lou, Ji-Zhuang, Kong, Wei, Chen, Jun-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014320/ https://www.ncbi.nlm.nih.gov/pubmed/29619900 http://dx.doi.org/10.1080/0886022X.2018.1456455

Ejemplares similares

The Association of Long-Functioning Hemodialysis Vascular Access with Prevalence of Left Ventricular Hypertrophy in Kidney Transplant Recipients
por: Kolonko, Aureliusz, et al.
Publicado: (2014)

Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients
por: Koycheva, Reneta Yovcheva, et al.
Publicado: (2016)

Electrocardiographic Left Ventricular Hypertrophy and Outcome in Hemodialysis Patients
por: Kim, Seung Jun, et al.
Publicado: (2012)

A retrospective study of baseline peritoneal transport character and left ventricular hypertrophy in incident peritoneal dialysis patients: interrelationship and prognostic impacts
por: Wang, Yi, et al.
Publicado: (2023)

Left Ventricular Hypertrophy Is Associated with Diastolic Filling Alterations in Normotensive Offspring of Hypertensive Nigerians
por: Kolo, P. M., et al.
Publicado: (2012)

The Polymorphism of the ACE Gene Affects Left Ventricular Hypertrophy and Causes Disturbances in Left Ventricular Systolic/Diastolic Function in Patients with Autosomal Dominant Polycystic Kidney Disease
por: Wanic-Kossowska, Maria, et al.
Publicado: (2014)

Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis
por: Al-Hilali, N., et al.
Publicado: (2009)

Potential Role of Mic60/Mitofilin in Parkinson’s Disease
por: Van Laar, Victor S., et al.
Publicado: (2019)

Crim1 suppresses left ventricular hypertrophy
por: Yang, Long, et al.
Publicado: (2019)

Carotid intima-media thickness and left ventricular hypertrophy in hemodialysis patients
por: Rafieian-Kopaei, Mahmoud, et al.
Publicado: (2013)

QTc and QTcd Measurements and Their Relationships with Left Ventricular Hypertrophy in Hemodialysis Patients
por: Yasri, Sora, et al.
Publicado: (2018)

Uric acid and left ventricular hypertrophy: another relationship in hemodialysis patients
por: Selim, Gjulsen, et al.
Publicado: (2019)

Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients
por: Braunisch, Matthias C., et al.
Publicado: (2021)

Regression of Left Ventricular Hypertrophy in Patients Combined with Peritoneal Dialysis and Hemodialysis
por: Luyan, Gao, et al.
Publicado: (2022)

Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants
por: Zhao, Xinju, et al.
Publicado: (2022)

Morning blood pressure surge in early autosomal dominant polycystic kidney disease and its relation with left ventricular hypertrophy
por: Yildiz, Abdülmecit, et al.
Publicado: (2021)

Mitofilin Mitigates Myocardial Damage in Acute Myocardial Infarction by Regulating Pyroptosis of Cardiomyocytes
por: Ma, Min, et al.
Publicado: (2022)

Independent Value of Cardiac Troponin T and Left Ventricular Global Longitudinal Strain in Predicting All-Cause Mortality among Stable Hemodialysis Patients with Preserved Left Ventricular Ejection Fraction
por: Sung, Junne-Ming, et al.
Publicado: (2014)

Vascular calcification and left ventricular hypertrophy in hemodialysis patients: interrelationship and clinical impacts
por: Hwang, Hyeon Seok, et al.
Publicado: (2018)

Relationship between doses of antihypertensive drugs and left ventricular mass index changes in hemodialysis patients in a Japanese cohort
por: Kitamura, Fumiya, et al.
Publicado: (2021)

Improved scoring system for the electrocardiographic diagnosis of left ventricular hypertrophy
por: Braunstein, Eric D, et al.
Publicado: (2019)

Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial
por: Wu, Lili, et al.
Publicado: (2020)

Close association of arterial plaques with left ventricular hypertrophy and ejection fraction in hemodialysis patients
por: Mowlaie, Morteza, et al.
Publicado: (2014)

Reproducibility and Reliability Of QTc and QTcd Measurements and Their Relationships with Left Ventricular Hypertrophy in Hemodialysis Patients
por: Alonso, Maria Angélica Gonçalves, et al.
Publicado: (2017)

Vitamin D receptor gene polymorphism predicts left ventricular hypertrophy in maintenance hemodialysis
por: Liu, Bingman, et al.
Publicado: (2022)

Research Progress on the Efficacy and Safety of Spironolactone in Reversing Left Ventricular Hypertrophy in Hemodialysis Patients
por: Sun, Zuoya, et al.
Publicado: (2023)

Correlation research between osteoporosis and left ventricular hypertrophy in older men
por: Huang, Chenshu, et al.
Publicado: (2016)

Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients
por: Snelder, Sanne M., et al.
Publicado: (2020)

Moexipril and left ventricular hypertrophy
por: Chrysant, George S, et al.
Publicado: (2007)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice
por: Lv, Ya-Jie, et al.
Publicado: (2018)

Protein Carbonyl Content Is a Predictive Biomarker of Eccentric Left Ventricular Hypertrophy in Hemodialysis Patients
por: Dimitrijevic, Zorica M., et al.
Publicado: (2019)

Mitofilin and CHCHD6 physically interact with Sam50 to sustain cristae structure
por: Ding, Chengli, et al.
Publicado: (2015)

Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients
por: Reza, Nosheen, et al.
Publicado: (2021)

Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
por: Polo, Jorge Melero, et al.
Publicado: (2023)

Impact of parathyroidectomy among nondiabetic hemodialysis patients with severe hyperparathyroidism
por: Huang, Qing-xiu, et al.
Publicado: (2022)

Aortic Stiffness, Left Ventricle Hypertrophy, and Homogeneity of Ventricle Repolarization in Adult Dialyzed Patients
por: Zapolski, Tomasz, et al.
Publicado: (2012)

Deficiency of Tregs in hypertension‐associated left ventricular hypertrophy
por: Tang, Ying, et al.
Publicado: (2023)

Epidemiology investigation and analysis of patients with hemodialysis in Sichuan province of China
por: Zou, Yang, et al.
Publicado: (2019)

Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice: Erratum
por: Lv, Ya-Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sac90rkt5125agfsoljgqi63pa